Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Pfizer turns to ChemAxon for cheminformatics solution

Share this on social media:

ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.

'Markush structure search and enumeration is becoming of critical importance for structure IP and patent development,' said Alex Drijver, CEO of ChemAxon. 'It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.'